Scott Gottlieb

Managing Director at T. R. Winston & Company LLC

Scott Gottlieb

Scott Gottlieb

Managing Director at T. R. Winston & Company LLC

Overview
RelSci Relationships

4517

Number of Boards

14

Birthday

1973

Age

45

Relationships
RelSci Relationships are individuals Scott Gottlieb likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Genoptix, Inc.

Relationship likelihood: Strong

Founder at Tolero Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Gradalis, Inc.

Relationship likelihood: Strong

Consulting Professor at Stanford University

Relationship likelihood: Strong

Co-Founder at Gradalis, Inc.

Relationship likelihood: Strong

Co-Founder at The Halifax Group LLC

Relationship likelihood: Strong

Co-Founder at X4 Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman at Tolero Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at The Keystone Center

Relationship likelihood: Strong

Executive Officer at HVC Management Co. LLC

Relationship likelihood: Strong

Paths to Scott Gottlieb
Potential Connections via
Relationship Science
You
Scott Gottlieb
Managing Director at T. R. Winston & Company LLC
Education
MD

The School commits to dramatically advancing the art and science of medical care through an atmosphere of intense collaborative learning, social concern, and scholarly inquiry.

B.A. in Economics

Wesleyan University is known for the excellence of its academic and co-curricular programs. About 2,900 undergraduates—and some 200 graduate students—from around the world pursue their classroom studies, research projects, and co-curricular interests in ways that are demanding and intensely rewarding. Here, on a beautiful campus overlooking the Connecticut River, students learn to do productive and innovative work that makes a positive difference in the world—that’s what Wesleyan is about.

Career History
Commissioner
Current

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), and veterinary products. The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction. The FDA is led by the Commissioner of Food and Drugs, appointed by the President with the advice and consent of the Senate. The Commissioner reports to the Secretary of Health and Human Services. The 21st and current Commissioner is Dr. Margaret A. Hamburg. She has served as Commissioner since May 2009. The FDA has its headquarters in unincorporated White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands, and Puerto Rico. In 2008, the FDA started opening offices in foreign countries, including China, India, Costa Rica, Chile, Belgium, and the United Kingdom. In June 1906, President Theodore Roosevelt signed into law the Food and Drug Act, also known as the "Wiley Act" after its chief advocate Dr. Harvey Washington Wiley who riveted the country's and eventually congress's attention with public hygiene demonstrations. This act was the basis for the modern USFDA, being originally given the name of the Food, Drug, and Insecticide organization. The name eventually was shortened to the Food and Drug Administration (FDA) a few years later.

Managing Director
Current
Commissioner, Food & Drug Administration (FDA)
Current

The United States Department of Health and Human Services (HHS), also known as the Health Department, is a cabinet-level department of the U.S. federal government with the goal of protecting the health of all Americans and providing essential human services. Its motto is "Improving the health, safety, and well-being of America". Before the separate federal Department of Education was created in 1979, it was called the Department of Health, Education, and Welfare (HEW).

Boards & Committees
Director
Current

MedAvante, Inc. provides signal detection solutions in clinical trials of treatments for central nervous system disorders. It offers Virgil investigative study platform for site-based assessments; and MedAvante central ratings for live assessments. The firm also offers scientific risk reduction services. The company was founded by Paul M. Gilbert, Amy Ellis, Peter B. Tilles, Livingston Johnson and Avik Roy in 2002 and is headquartered in Hamilton, NJ.

Director
Current

Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT.

Director
Current

Aptiv Solutions, Inc. provides biological research and development services. It offers adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing, and the operational support of a global clinical research organization. The company was founded in 1983 and is headquartered in Reston, VA.

Member, Advisory Board
Current

Cancer Commons aims to provide patients and their physicians with the knowledge needed to select the best available therapies and trials, and to continuously update that knowledge based on each patient’s response.

Non-Voting Ex Officio Member, Board of Directors
Current

The Foundation leverages NIH's science with private-sector support for biomedical advances that benefit people around the world. As a non-profit organization, the Foundation serves donors who wish to support biomedical research by building on the resources and talent at NIH in specific areas of interest. In addition, the Foundation supports training and advanced education programs for the investigators of tomorrow and invests in educational programs about medical research.

Trustee
Tenure Unconfirmed

Keystone Policy Center inspires leaders to rise above entrenched positions to reach common higher ground.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $10K
2011

Keystone Policy Center inspires leaders to rise above entrenched positions to reach common higher ground.

Political Donations
$2,000
2015

Representative from Minnesota's 3rd Congressional District

$300
2014

The Republican National Committee (RNC) is a U.S. political committee that provides national leadership for the Republican Party of the United States. It is responsible for developing and promoting the Republican political platform, as well as coordinating fundraising and election strategy. It is also responsible for organizing and running the Republican National Convention. Similar committees exist in every U.S. state and most U.S. counties, although in some states party organization is structured by congressional district, allied campaign organizations being governed by a national committee. Reince Priebus is the current RNC Chairman.

$2,400
2013

Senator at Office of the Senator from Louisiana, Bill Cassidy

Events
Speaker
New York City, NY
4th Annual Partnering for Cures

Partnering for Cures is FasterCures' annual meeting that brings together diverse participants to discuss and solve the crucial issues facing the medical research world today. Partnering for Cures is structured with thought-provoking panels that host well-known speakers from the different sectors of the medical world; presenters from organizations that are boasting innovative approaches to the issues facing health; pro-bono, personalized advice from experts across medical research fields; and a unique partnering systems that allows conference participants to schedule meetings throughout the weekend to collaborate and create new approaches to save and improve lives.

Speaker
2018 World Economic Forum Annual Meeting

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Scott Gottlieb. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Scott Gottlieb's profile does not indicate a business or promotional relationship of any kind between RelSci and Scott Gottlieb.